MediWound (MDWD) Income from Discontinued Operations (2013 - 2020)
MediWound (MDWD) posted Income from Discontinued Operations of $3000.0 for Q4 2020, up 103.61% on a QoQ basis from -$83000.0 in Q3 2020, and up 103.61% year-over-year from $1473.4 in Q1 2020.
Powered by 
Analysis
MediWound (MDWD) Income from Discontinued Operations (2013 - 2020) Analysis & Trends
MediWound has reported Income from Discontinued Operations for 6 years, with the latest figure at $3000.0 in Q4 2020.
- On a quarterly basis, Income from Discontinued Operations rose 103.61% year-over-year to $3000.0 in Q4 2020; TTM through Jun 2021 was -$80000.0, a 102.85% decrease from a year earlier, with the FY2020 full-year figure at -$80000.0, up 97.23% from the prior year.
- Income from Discontinued Operations was $3000.0 for Q4 2020 at MediWound, up from -$83000.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was $2.9 million in Q3 2019, with the low at -$7.5 million in Q3 2017.
- Average Income from Discontinued Operations over 3 years is -$672571.4, with a median of -$50000.0 recorded in 2019.
- The largest YoY upside for Income from Discontinued Operations was 103.61% in 2020 against a maximum downside of 102.87% in 2020.
- Over 3 years, Income from Discontinued Operations stood at $116000.0 in 2017, then plunged by 171.55% to -$83000.0 in 2019, then soared by 103.61% to $3000.0 in 2020.
- The last three Income from Discontinued Operations figures came in at $3000.0 (Q4 2020), -$83000.0 (Q3 2020), and -$83000.0 (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 3,000.00 |
| Sep 30, 2020 | -83,000.00 |
| Dec 31, 2019 | -83,000.00 |
| Sep 30, 2019 | 2.89 Mn |
| Mar 31, 2019 | -50,000.00 |
| Dec 31, 2017 | 116,000.00 |
| Sep 30, 2017 | -7.50 Mn |
| Mar 31, 2015 | -417,000.00 |
| Jun 30, 2014 | 14,000.00 |
| Mar 31, 2014 | -14,000.00 |
| Dec 31, 2013 | -180,000.00 |
| Sep 30, 2013 | -4.74 Mn |
| Jun 30, 2013 | 1.08 Mn |
| Mar 31, 2013 | -845,000.00 |